Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway.

OBJECTIVE Obstructive sleep apnea syndrome (OSAS) is associated with many cardiovascular disorders. Chronic intermittent hypoxia (CIH) is the primary player in OSAS of the many associated factors. This study was in order to investigate the effects of the Adiponectin (Ad) on left ventricular remodeling induced by CIH. METHODS Forty-five rats were randomly divided into three groups: normal control (NC) group, CIH group and CIH plus Ad supplemented (CIH + Ad) group. After 35 days' CIH exposure, masson analysis was used to detect the left ventricular fibrosis and western blot was used to measure the protein expression of collagen I, collagen III and TGF-β/smad2/3 pathway. Gene analysis by RT-PCR was used to study the MMP2 and TIMP2. RESULTS After CIH exposure, the fibrosis of left ventricular in CIH group was significantly remarkable than that in both NC and CIH + Ad groups (P<0.05), although statistical difference existed between NC and CIH + Ad groups (P<0.05). In addition, the protein expression of collagen I as well as collagen III and the ratio of mRNA levels of MMP2/TIMP2 were the highest in CIH group but the lowest in NC group, with CIH + Ad group in between. There was a significant difference among three groups (all P<0.05). The TGF-β/smad2/3 pathway was activated obviously in CIH group, but less noticeably in CIH + Ad group (P<0.05) with a significant difference in the two groups. CONCLUSIONS The present study showed that Ad could ameliorate the left ventricular remodeling induced by CIH via inhibition of the expression of TGF-β/smad2/3 pathway.

[1]  Shi-jiang Zhang,et al.  Adiponectin Protects Rat Myocardium against Chronic Intermittent Hypoxia-Induced Injury via Inhibition of Endoplasmic Reticulum Stress , 2014, PloS one.

[2]  S. Tyagi,et al.  Cardiac matrix: a clue for future therapy. , 2013, Biochimica et biophysica acta.

[3]  A. Garnier,et al.  Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure , 2013, Heart Failure Reviews.

[4]  H. Mizoguchi,et al.  Roles of Matrix Metalloproteinases and Their Targets in Epileptogenesis and Seizures , 2013, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[5]  M. Rossi,et al.  Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. , 2013, Experimental and molecular pathology.

[6]  K. Cho,et al.  Impact of obstructive sleep apnea on left atrial functional and structural remodeling beyond obesity. , 2012, Journal of cardiology.

[7]  R. Grewal.  Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea. , 2012, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[8]  Prabhakaran Gopalakrishnan,et al.  Obstructive Sleep Apnea and Cardiovascular Disease , 2011, Cardiology in review.

[9]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[10]  T Douglas Bradley,et al.  Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. , 2011, Journal of the American College of Cardiology.

[11]  K. Philipson,et al.  The Na+/Ca2+ exchanger-1 mediates left ventricular dysfunction in mice with chronic intermittent hypoxia. , 2010, Journal of applied physiology.

[12]  T. Leff,et al.  Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism. , 2010, American journal of physiology. Heart and circulatory physiology.

[13]  T. Murohara,et al.  Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. , 2010, Journal of molecular and cellular cardiology.

[14]  M. Rossi,et al.  Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension. , 2010, Journal of cardiac failure.

[15]  Y. Kitaura,et al.  Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice , 2010, Hypertension Research.

[16]  S. Takai,et al.  Chymase Plays an Important Role in Left Ventricular Remodeling Induced by Intermittent Hypoxia in Mice , 2009, Hypertension.

[17]  S. Kihara,et al.  Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[18]  K. Walsh,et al.  Cardioprotection by adiponectin. , 2006, Trends in cardiovascular medicine.

[19]  C. Balke,et al.  Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. , 2005, American journal of respiratory and critical care medicine.

[20]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[21]  Noriko Kando,et al.  Two-Stage Refinement of Query Translation in a Pivot Language Approach to Cross-Lingual Information Retrieval: An Experiment at CLEF 2003 , 2003, CLEF.

[22]  P. Froguel,et al.  Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.

[23]  T. Yoshizaki,et al.  Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review). , 2002, Oncology reports.

[24]  F. Yasuma,et al.  Long-term treatment of ischemic dilated cardiomyopathy with continuous positive airway pressure. , 2001, Internal medicine.

[25]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  V. Petrov,et al.  Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.

[27]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[28]  M. Eghbali,et al.  Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. , 1991, Circulation research.

[29]  R. Samarakoon,et al.  TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. , 2013, Cellular signalling.

[30]  C. Balke,et al.  Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. , 2008, Journal of applied physiology.

[31]  R. Derynck,et al.  Specificity and versatility in tgf-beta signaling through Smads. , 2005, Annual review of cell and developmental biology.

[32]  S. Rosenkranz,et al.  Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). , 2002, American journal of physiology. Heart and circulatory physiology.

[33]  F. Spinale.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .